JORDYN SAMPSON: Open Payments
NPI 1710733415 · JAMESTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,188 in 51 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $597 · 2025 $1,188
Food & beverage: $1,188
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 3 | $159 |
| PFIZER INC. | 8 | $144 |
| Novo Nordisk Inc | 5 | $113 |
| Viatris Specialty LLC | 3 | $112 |
| AstraZeneca Pharmaceuticals LP | 5 | $110 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $94 |
| GlaxoSmithKline, LLC. | 4 | $83 |
| Exact Sciences Corporation | 3 | $70 |
| Lilly USA, LLC | 4 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
Products named: DEXCOM G7 GSS (161), YUPELRI, Kerendia, NURTEC ODT, TRELEGY ELLIPTA, CAPLYTA, Wegovy, WATCHMAN FLX.
Industry payments across NY — which companies pay providers there.
